Biliary and pancreatic diseases in need of cholangiopancreatoscopy diagnosis and treatment
Conditions
Interventions
cholangiopancreatoscopy diagnosis and treatment using the Spyglass system
Sponsors
Tokyo Medical University, Department of Gastroenterology and Hepatology
1. Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo 2. First Department of Internal Medicine, Gifu University Hospital, Gifu 3. Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 4. Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, Chiba 5. Department of Gastroenterology, Chiba Cancer Center, Funabashi Municipal Hospital, Chiba 6. Department of Gastroenterology, National Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: an indication for cholangiopancreatoscopy
Exclusion criteria
Exclusion criteria: Excluded were patients with bleeding diatheses, distorted anatomy, severe jaundice or cholangitis, critically ill patients, and patients who were not able to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main outcomes were related to the procedure success rate | — |
Secondary
| Measure | Time frame |
|---|---|
| occurrence rate and kinds of adverse events | — |
Countries
Japan
Contacts
Public ContactTakao Itoi
Tokyo Medical University Department of Gastroenterology and Hepatology
Outcome results
None listed